PMDA drug package insert
ロサルヒド配合錠LD「三和」
PMDA Prescription drug · 株式会社三和化学研究所 · package insert Aug 19, 2026
Key facts
| Brand names | ロサルヒド配合錠LD「三和」, ロサルヒド配合錠HD「三和」 |
|---|---|
| Nonproprietary names | ロサルタンカリウム・ヒドロクロロチアジド配合剤 |
| Companies | 製造販売元／株式会社三和化学研究所 |
| Product type | Prescription drug |
| Therapeutic category | 持続性ARB/利尿薬合剤 |
| Therapeutic category codes | 872149 |
| YJ codes | 2149110F1236, 2149110F2070 |
| Approval numbers | 22600AMX00388000, 22700AMX00815000 |
| Package insert edition | 第4版 |
| Package insert date | Aug 19, 2026 |
| PMDA document key | 300297_2149110F1236_1 |
| PMDA company code | 300297 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: